Horizon Pharma offers to buy Depomed in $3 billion deal
July 07, 2015 at 07:19 AM EDT
July 7 (Reuters) - Ireland-based Horizon Pharma Plc said it offered to buy Depomed Inc in a deal valued at about $3 billion, taking its bid for the smaller drugmaker hostile.
